nejmoa1607141See also Advancements in Dementia Treatment: How CBD Holds Promise for PatientsPost navigation Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes